Search

everythinglearnresearchcommunity

for

Search:↓

Most women with excess male hormones have Polycystic Ovary Syndrome, and hormonal therapy can improve symptoms but may cause side effects.

Minoxidil effectively treats female pattern hair loss.

MENT could be a better option than testosterone for male hormone therapy and birth control because it works well at lower doses and has fewer side effects on the prostate.

Cats with Feline Symmetrical Alopecia can regrow hair with proper treatment based on the specific cause, including diet, medication, or stress management.

Common skin conditions can greatly affect a person's mental health and social life.

Cyproterone acetate is the preferred treatment for women's hyperandrogenism when estrogen/progestogen use is safe.

Androgen replacement therapy can improve libido and mood in women with severe androgen deficiency, but more research is needed on its long-term safety.

5-alpha reductase inhibitors can cause sexual side effects like erectile dysfunction and reduced sexual desire, sometimes lasting after stopping the drug.

Menopausal acne is treated with medications and lifestyle changes, but careful choice is needed due to side effects.

Androgen therapy can help with symptoms like low libido in women, but more research is needed to understand its long-term safety and effects on health.

Androgenetic alopecia involves genetics, hormones, and can be treated with medications or surgery.

FAGA diagnosis uses blood tests and trichoscopy, with treatments like topical minoxidil, oral anti-androgens, and hormone-modulating drugs.

The document says that understanding the causes of PCOS is important for treatment, especially in distinguishing the syndrome from just having cystic ovaries, and that losing weight is key for obese women with PCOS.

Cooling the scalp may prevent hair loss from chemotherapy, hair often grows back after treatment, and nail issues usually improve after stopping the drug.

Monitoring for adverse effects in clinical treatments is crucial.

The document concludes that managing skin conditions during pregnancy is important and requires specialized care.

Castration is preferred for non-breeding male dogs with BPH, but other treatments are available with specific pros and cons.

C60 fullerenes can alter protein function and may help develop new disease inhibitors.

To manage diffuse hair loss, identify the cause, improve nutrition, remove triggers, and use specific treatments like minoxidil or finasteride.

Hormonal treatments can help with acne but are not the first choice due to side effects and the need for careful patient selection.

Male hormones are important for hair and oil gland development and can cause conditions like excessive hair growth and acne.

The document suggests that clinical trials for PCOS should focus on meaningful primary outcomes like live birth rates, rather than less reliable surrogate markers.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

The document concludes that health care providers should offer culturally competent care and more research is needed to improve health outcomes for transgender individuals.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

Unwanted facial hair significantly impacts over 40% of women's psychological and social well-being, and various treatment options are available.

The document concludes that proper diagnosis and tailored long-term treatment can effectively manage androgenic disorders in women, improving patient care outcomes.

The document concludes that gender-affirming treatments are essential for transgender individuals and outlines safe hormone therapy practices.

5α-reductase inhibitors can interfere with doping tests by masking banned substances.

Cyproterone acetate may cause liver cancer at high doses, but is considered safe at recommended doses for approved uses.